AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69
HEPATITIS-C VIRUS (HCV) INFECTION AND BONE-MARROW TRANSPLANTATION (BMT) - A PROSPECTIVE-STUDY WITH 10-YEAR FOLLOW-UP
Authors: STRASSER SL SPURGEON CL KIM S SCHOCH HG MYERSON D SULLIVAN KM MCDONALD GB
Citation: Sl. Strasser et al., HEPATITIS-C VIRUS (HCV) INFECTION AND BONE-MARROW TRANSPLANTATION (BMT) - A PROSPECTIVE-STUDY WITH 10-YEAR FOLLOW-UP, Hepatology, 28(4), 1998, pp. 453-453
IS GVHD A MODEL OF PBC - CHARACTERIZATION OF AUTOANTIBODIES IN GVHD
Authors: QUARANTA S SHULMAN H PAGANIN S SHOENFELD Y AHMED A PETER J LEUNG PSC VANDEWATER J COPPEL R OSTLUND C WORMAN HJ RIZZETTO M TSUNEYAMA K MCDONALD GB ROSINA F GERSHWIN ME
Citation: S. Quaranta et al., IS GVHD A MODEL OF PBC - CHARACTERIZATION OF AUTOANTIBODIES IN GVHD, Hepatology, 28(4), 1998, pp. 1516-1516
PLASMA THROMBOPOIETIN LEVELS IN MARROW TRANSPLANT PATIENTS WITH VENOOCCLUSIVE DISEASE OF THE LIVER
Authors: OH H TAHARA T BOUVIER M FARRAND A MCDONALD GB
Citation: H. Oh et al., PLASMA THROMBOPOIETIN LEVELS IN MARROW TRANSPLANT PATIENTS WITH VENOOCCLUSIVE DISEASE OF THE LIVER, Bone marrow transplantation, 22(7), 1998, pp. 675-679
IRON OVERLOAD IN BONE-MARROW TRANSPLANT RECIPIENTS
Authors: STRASSER SI KOWDLEY KV SALE GE MCDONALD GB
Citation: Si. Strasser et al., IRON OVERLOAD IN BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 22(2), 1998, pp. 167-173
THE EFFECT OF PROPHYLACTIC FLUCONAZOLE ON THE CLINICAL SPECTRUM OF FUNGAL DISEASES IN BONE-MARROW TRANSPLANT RECIPIENTS WITH SPECIAL ATTENTION TO HEPATIC CANDIDIASIS - AN AUTOPSY STUDY OF 355 PATIENTS
Authors: VANBURIK JAH LEISENRING W MYERSON D HACKMAN RC SHULMAN HM SALE GE BOWDEN RA MCDONALD GB
Citation: Jah. Vanburik et al., THE EFFECT OF PROPHYLACTIC FLUCONAZOLE ON THE CLINICAL SPECTRUM OF FUNGAL DISEASES IN BONE-MARROW TRANSPLANT RECIPIENTS WITH SPECIAL ATTENTION TO HEPATIC CANDIDIASIS - AN AUTOPSY STUDY OF 355 PATIENTS, Medicine, 77(4), 1998, pp. 246-254
ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF INTESTINAL GRAFT-VERSUS-HOST DISEASE - A RANDOMIZED, CONTROLLED TRIAL
Authors: MCDONALD GB BOUVIER M HOCKENBERY DM STERN JM GOOLEY T FARRAND A MURAKAMI C LEVINE DS
Citation: Gb. Mcdonald et al., ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF INTESTINAL GRAFT-VERSUS-HOST DISEASE - A RANDOMIZED, CONTROLLED TRIAL, Gastroenterology, 115(1), 1998, pp. 28-35
SEVERE GASTROINTESTINAL-BLEEDING AFTER MARROW TRANSPLANTATION, 1987-1997 - INCIDENCE, CAUSES, AND OUTCOME
Authors: SCHWARTZ JM STRASSER SI LOPEZCUBERO SO MURAKAMI CS HOCKENBERY DM MCDONALD GB
Citation: Jm. Schwartz et al., SEVERE GASTROINTESTINAL-BLEEDING AFTER MARROW TRANSPLANTATION, 1987-1997 - INCIDENCE, CAUSES, AND OUTCOME, Gastroenterology, 114(4), 1998, pp. 161-161
COURSE OF CROHNS-DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
Authors: LOPEZCUBERO SO SULLIVAN KM MCDONALD GB
Citation: So. Lopezcubero et al., COURSE OF CROHNS-DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION, Gastroenterology, 114(3), 1998, pp. 433-440
PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND ITS METABOLITES IN BONE-MARROW TRANSPLANTATION PATIENTS
Authors: REN S KALHORN TF MCDONALD GB ANASETTI C APPELBAUM FR SLATTERY JT
Citation: S. Ren et al., PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND ITS METABOLITES IN BONE-MARROW TRANSPLANTATION PATIENTS, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 289-301
SERIAL MEASUREMENT OF SERUM HYALURONIC-ACID IN VENOOCCLUSIVE DISEASE (VOD) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) - CORRELATION WITH SEVERITY
Authors: FRIED MW DUNCAN A SOROKA S CONNAGHAN DG FARRAND A STRAUSS RM BOYER TD MCDONALD GB
Citation: Mw. Fried et al., SERIAL MEASUREMENT OF SERUM HYALURONIC-ACID IN VENOOCCLUSIVE DISEASE (VOD) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) - CORRELATION WITH SEVERITY, Hepatology, 26(4), 1997, pp. 82-82
VENOCCLUSIVE DISEASE OF THE LIVER AFTER HIGH-DOSE CHEMOTHERAPY WITH ALKYLATING-AGENTS - INCIDENCE, OUTCOME, AND RISK-FACTORS
Authors: LEE JL GOOLEY T BENSINGER W SCHIFFMAN K MCDONALD GB
Citation: Jl. Lee et al., VENOCCLUSIVE DISEASE OF THE LIVER AFTER HIGH-DOSE CHEMOTHERAPY WITH ALKYLATING-AGENTS - INCIDENCE, OUTCOME, AND RISK-FACTORS, Hepatology, 26(4), 1997, pp. 83-83
GRAFT-VERSUS-HOST DISEASE (GVHD) OF THE LIVER IN RECIPIENTS OF AUTOLOGOUS HEMATOPOIETIC STEM-CELLS
Authors: SAUNDERS MD MURAKAMI CS SHULMAN HM CHAUNCEY TR MCDONALD GB
Citation: Md. Saunders et al., GRAFT-VERSUS-HOST DISEASE (GVHD) OF THE LIVER IN RECIPIENTS OF AUTOLOGOUS HEMATOPOIETIC STEM-CELLS, Hepatology, 26(4), 1997, pp. 1092-1092
CIRCULATING MARKERS OF HEPATIC-FIBROSIS PREDICT EVOLUTION OF VENOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTION
Authors: SCHUPPAN D FARRAND A OESTERLING C GEHRMANN M MCDONALD GB
Citation: D. Schuppan et al., CIRCULATING MARKERS OF HEPATIC-FIBROSIS PREDICT EVOLUTION OF VENOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTION, Hepatology, 26(4), 1997, pp. 1294-1294
CHRONIC GRAFT-VS-HOST DISEASE (GVHD) OF THE LIVER - PRESENTATION AS AN ACUTE HEPATITIS
Authors: STRASSER SI SHULMAN HM MCDONALD GB
Citation: Si. Strasser et al., CHRONIC GRAFT-VS-HOST DISEASE (GVHD) OF THE LIVER - PRESENTATION AS AN ACUTE HEPATITIS, Hepatology, 26(4), 1997, pp. 1908-1908
ACUTE-PANCREATITIS IN MARROW TRANSPLANT PATIENTS - PREVALENCE AT AUTOPSY AND RISK FACTOR-ANALYSIS
Authors: KO CW GOOLEY T SCHOCH HG MYERSON D HACKMAN RC SHULMAN HM SALE GE LEE SP MCDONALD GB
Citation: Cw. Ko et al., ACUTE-PANCREATITIS IN MARROW TRANSPLANT PATIENTS - PREVALENCE AT AUTOPSY AND RISK FACTOR-ANALYSIS, Bone marrow transplantation, 20(12), 1997, pp. 1081-1086
HEPATITIS-ASSOCIATED APLASTIC-ANEMIA
Authors: KIEM HP STORB R MCDONALD GB
Citation: Hp. Kiem et al., HEPATITIS-ASSOCIATED APLASTIC-ANEMIA, The New England journal of medicine, 337(6), 1997, pp. 424-425
A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF INTESTINAL GRAFT-VS-HOST DISEASE
Authors: MCDONALD GB BOUVIER M STERN JG GOOLEY T FARRAND A LEVINE DS
Citation: Gb. Mcdonald et al., A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF INTESTINAL GRAFT-VS-HOST DISEASE, Gastroenterology, 112(4), 1997, pp. 1037-1037
PROLONGED REMISSIONS OF CROHNS-DISEASE FOLLOWING ALLOGENEIC MARROW TRANSPLANTION
Authors: MCDONALD GB LOPEZCUBERO SO SULLIVAN KM
Citation: Gb. Mcdonald et al., PROLONGED REMISSIONS OF CROHNS-DISEASE FOLLOWING ALLOGENEIC MARROW TRANSPLANTION, Gastroenterology, 112(4), 1997, pp. 1037-1037
ACUTE GRAFT-VERSUS-HOST DISEASE OF THE ESOPHAGUS
Authors: LOPEZCUBERO SO SALE GE MCDONALD GB
Citation: So. Lopezcubero et al., ACUTE GRAFT-VERSUS-HOST DISEASE OF THE ESOPHAGUS, Endoscopy, 29(7), 1997, pp. 35-36
PREVALENCE OF HEPATITIS-G VIRUS IN PATIENTS WITH APLASTIC-ANEMIA
Authors: KIEM HP MYERSON D STORB R MCDONALD GB SPURGEON CL LEISENRING W
Citation: Hp. Kiem et al., PREVALENCE OF HEPATITIS-G VIRUS IN PATIENTS WITH APLASTIC-ANEMIA, Blood, 90(3), 1997, pp. 1335-1336
NO ASSOCIATION BETWEEN ACTIVATED PROTEIN-C (APC) RESISTANCE AND HEPATIC VENOOCCLUSIVE DISEASE (VOD) FOLLOWING STEM-CELL TRANSPLANTATION
Authors: CHAUNCEY TR THOMPSON AR STEWART L GOOLEY T MCDONALD GB
Citation: Tr. Chauncey et al., NO ASSOCIATION BETWEEN ACTIVATED PROTEIN-C (APC) RESISTANCE AND HEPATIC VENOOCCLUSIVE DISEASE (VOD) FOLLOWING STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4353-4353
MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION
Authors: SLATTERY JT CLIFT RA BUCKNER CD RADICH J STORER B BENSINGER WI SOLL E ANASETTI C BOWDEN R BRYANT E CHAUNCEY T DEEG HJ DONEY KC FLOWERS M GOOLEY T HANSEN JA MARTIN PJ MCDONALD GB NASH R PETERSDORF EW SANDERS JE SCHOCH G STEWART P STORB R SULLIVAN KM THOMAS ED WITHERSPOON RP APPELBAUM FR
Citation: Jt. Slattery et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION, Blood, 89(8), 1997, pp. 3055-3060
TREATMENT OF HEPATIC VENOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR AND HEPARIN IN 42 MARROW TRANSPLANT PATIENTS
Authors: BEARMAN SI LEE JL BARON AE MCDONALD GB
Citation: Si. Bearman et al., TREATMENT OF HEPATIC VENOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR AND HEPARIN IN 42 MARROW TRANSPLANT PATIENTS, Blood, 89(5), 1997, pp. 1501-1506
CRITICAL CARE ISSUES IN MARROW TRANSPLANTATION - INTESTINAL AND LIVERCOMPLICATIONS
Authors: SINGH C MCDONALD GB
Citation: C. Singh et Gb. Mcdonald, CRITICAL CARE ISSUES IN MARROW TRANSPLANTATION - INTESTINAL AND LIVERCOMPLICATIONS, Seminars in respiratory and critical care medicine, 17(5), 1996, pp. 385-393
CONDITIONING REGIMEN-DEPENDENT DISPOSITION OF CYCLOPHOSPHAMIDE AND HYDROXYCYCLOPHOSPHAMIDE IN HUMAN MARROW TRANSPLANTATION PATIENTS
Authors: SLATTERY JT KALHORN TF MCDONALD GB LAMBERT K BUCKNER CD BENSINGER WI ANASETTI C APPELBAUM FR
Citation: Jt. Slattery et al., CONDITIONING REGIMEN-DEPENDENT DISPOSITION OF CYCLOPHOSPHAMIDE AND HYDROXYCYCLOPHOSPHAMIDE IN HUMAN MARROW TRANSPLANTATION PATIENTS, Journal of clinical oncology, 14(5), 1996, pp. 1484-1494
Risultati: 1-25 | 26-50 | 51-69